2015年6月25日，温州医科大学实验医学与生命科学学院的Shouhua Lai (第一作者) & Yunting Guo (第一作者) & Tieli Zhou (通讯作者 音译 周铁丽) & Jiegen Jiang (通讯作者) & Jimin ...

Cell and gene therapy: Dr. Jeff Hersh examines 25 years of technological advances In general, earlier stage cancers have ...

Vallina, from the CRIS Immuno-Oncology Unit, in Madrid (Spain), explains that a new approach provides 'trained troops' of ...

正在西班牙巴塞罗那召开的2024年欧洲肿瘤内科学会（ESMO）大会上，中山大学肿瘤防治中心徐瑞华教授以口头报告形式公布了一项Ⅰ期临床研究的初步 数据 1 。 该研究评估了新型抗体偶联药物（ADC）SHR-A1904用于Claudin18.2阳性的胃癌 ...

这种GRF-GIF遗传转化系统为高难度、高效率的大豆基因工程提供了一条新路径，未来可能在农业生产中发挥重要作用。随着研究的深入，科学家们有望在大豆及其他作物的改良上取得更多突破，将基因技术的潜能转化为实际的生产力。

T-cell therapy has increased rapidly, the clinical benefit seen with these products comes at a cost for patients who experience toxicities related to the induction of a powerful immune response. The ...

Researchers mined the molecular foundations of cancer and uncovered a new reason chimeric antigen receptor (CAR-T cell therapy) fails in some patients. This discovery has fueled new strategies that ...

Legend Biotech's valuation is conservative, suggesting potential for significant appreciation and growth ahead. Click here to ...

Adicet Bio (ACET) reported ADI-001 clinical biomarker data from the Phase 1 GLEAN trial which further reinforces the potential of ...

Tampa General has been working on its own growth initiatives. Last month, the system said it planned to invest more than $162 ...